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Background: The University Of Michigan Hospital has implemented a guideline-based system to maximize acute coronary syndrome care over 
the past 10 years. Our goal for this study is to look at the use of clinical practice guidelines in recent years in the management of acute coronary 
syndrome (ACS) patients in this hospital, and to assess their impact on outcomes.
Methods: We evaluated 3623 consecutive Acute Coronary Syndrome (ACS) patients who were admitted or transferred to our health center from 
1999 to 2006. Linear by linear association and analysis of variance were used to compare the groups.
Results: Over time there was a significant increase in the chronic medications use in patients prior to their ACS admission. A similar increasing 
trend was seen in Percutaneous Coronary Intervention (PCI), smoking cessation counseling and discharge medication use (table). There was a 
significant improvement in in-hospital and 6 month outcomes including death and myocardial infarction (table). At 6 months follow up there was 
higher rate of adherence with aspirin however there was 5 to 15% decrease in adherence with beta blockers, ACE inhibitor and statins in these high 
risk patients, just within six month of discharge (table). 
Conclusion: The guidelines based system, increase in PCI and better adherence to evidence based medicine translated in improved outcomes. 
We have nearly maximized the in-patient care but there is a strong need to provide a long term care to this high risk patient population outside the 
hospital. 
Year Of ACS 1999 2000 2001 2002 2003 2004 2005 2006** p value
PCI, % 40.2 41.2 39.9 41.9 50.4 54.9 47.9 51.1 <0.001
Rehabilitation referral,% NA 21 17.7 10.6 23.7 40.7 39.8 42.2 0.03
Smoking cessation counseling,% NA 91.8 77.1 * 89.4 86.3 95.3 95.7 <0.001
Discharge Aspirin ,% 83.1 87.1 87.3 91.2 91.3 94.4 95.2 96.7 <0.001
Discharge Beta-blocker,% 74.4 76.9 81.3 86.2 86.5 89.7 89.5 93.5 <0.001
Discharge Statin,% 64.5 60.0 63.9 77.0 77.6 88.5 91.3 87.0 <0.001
Discharge ACE inhibitor ,% 50.4 59.7 63.6 68.5 71.8 77.2 67.1 68.5 <0.001
Adherence Aspirin,% 84.9 88.5 89.7 91.0 92.9 95.5 90.8 96.4 <0.001
Adherence Beta-blocker,% 87.9 88.5 89.1 86.6 85.3 86.1 91.6 78.6 0.33
Adherence Statin,% 85.3 87.8 87.5 79.3 86.3 90.5 89.6 82.6 0.29
Adherence ACE Inhib. ,% 71.7 80.6 78.6 83.8 77.0 74.9 80.7 52.9 0.97
In-hospital Death,% 3.8 5.7 6.1 3.8 3.2 2.0 1.5 2.2 0.001
In-hospital MI 2.8 11.8 9.4 1.4 2.0 3.9 3.0 1.1 <0.001
6Month Death,% 4.3 7.6 10.6 4.4 6.5 3.1 5.5 0.0 0.09
6Month MI,% 5.0 24.0 8.9 6.5 4.8 2.8 7.6 14.7* 0.01
